?Gleiss Lutz has advised Pitango on the deal. Israeli venture capital investor Pitango announced its investment in digital health startup Patient21. The Berlin-based startup raised a...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz advised Curaleaf in the transaction while Paul Hastings represented Four 20 Pharma. Curaleaf Holdings, Inc., a leading U.S. provider of consumer products in cannabis,...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz and Chiomenti advised Investindustrial and Procemsa on the deal. Latham & Watkins acted for Farmaceutici Procemsa SpA. Gattai, Minoli, Partners assisted the banks. The...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Gleiss Lutz, advised on the matter. Gleiss Lutz advised Investindustrial with a team including Jan Balssen (Picture – Corporate M&A), Stefan Mayer (Tax M&A...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz advised Integer on the deal while Locke Lord represented Oscor. The US company Integer, a leading medical device outsource manufacturer, announced its USD 220...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Gleiss Lutz, advised on the matter. Gleiss Lutz advised Integer Holdings Corporation with a team including Johannes Hertfelder (Competition Law), Stefan Lingemann (Employment), Martin...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz, Kromann Reumert, Vinge, Loyens & Loeff and Fava & Associati advised Coloplast on the deal. Linklaters advised PAI Partners. Coloplast has signed an agreement...
You must be a Standard 1 Year member to access this content.
FPS Fritze Wicke Seelig advised Bloomwell Group on the deal. Gleiss Lutz advised Measure 8 Ventures. Noerr advises M4Capital. The Bloomwell Group has successfully closed a...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz advised Roche on the deal. Hengeler Mueller advised the shareholders of TIB Mobil Group on the transaction. The global pharmaceutical and diagnostics group Roche...
You must be a Standard 1 Year member to access this content.
